Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.

Molecular Cancer Therapeutics
Grazia AmbrosiniGary K Schwartz

Abstract

Malignant peripheral nerve sheath tumors (MPNST) are soft-tissue tumors with a very poor prognosis and largely resistant to chemotherapy. MPNSTs are characterized by activation of the Ras pathway by loss of tumor suppressor neurofibromatosis type 1. In view of this, MPNST may be susceptible to inhibition of the activated Ras/Raf/mitogen-activated protein kinase pathway by the B-Raf inhibitor sorafenib. MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized for Ras activation and B-Raf expression. Tumor cells were treated with sorafenib and examined for growth inhibition, inhibition of phospho-MEK, phospho-ERK, cell cycle arrest, and changes in cyclin D1 and pRb expression. MPNSTs were sensitive to sorafenib at nanomolar concentrations. This appeared to be due to inhibition of phospho-MEK, phospho-ERK, suppression of cyclin D1, and hypophosphorylation of pRb at the CDK4-specific sites, resulting in a G(1) cell cycle arrest. These effects were not seen in the liposarcoma cells, which either did not express B-Raf or showed decreased Ras activation. Small interfering RNA-mediated depletion of B-Raf in MPNSTs also induced a G(1) cell cycle arrest in these cells, with a ma...Continue Reading

References

Aug 23, 1996·The Journal of Biological Chemistry·J N LavoieJ Pouysségur
Feb 14, 2002·Trends in Molecular Medicine·Esther ZwickAxel Ullrich
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Oct 9, 2002·Current Pharmaceutical Design·Scott Wilhelm, Du-Shieng Chien
Sep 6, 2003·Cancer Cell·David A TuvesonMeenhard Herlyn
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pascale LévyDominique Vidaud
Aug 19, 2004·Cancer Chemotherapy and Pharmacology·Henry Q Xiong
Oct 19, 2004·Cancer Cell·Mathew J Garnett, Richard Marais
Apr 14, 2005·Molecular Cancer Therapeutics·Srikala S SridharLillian L Siu
Aug 19, 2005·The New England Journal of Medicine·Matthew A ClarkJ Meirion Thomas
Nov 8, 2005·Nature·David B SolitNeal Rosen
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Batya BarkanYoel Kloog
Mar 17, 2007·Molecular Cancer Therapeutics·Constantine S MitsiadesNicholas Mitsiades
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington

❮ Previous
Next ❯

Citations

Oct 20, 2009·Expert Reviews in Molecular Medicine·Daniela KatzDina Lev
Apr 14, 2012·Advances in Anatomic Pathology·Elizabeth G DemiccoAlexander J Lazar
Jun 16, 2012·Sarcoma·Juan Martín LiberalOscar M Tirado
Mar 13, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Markus P GhadimiDina Lev
Aug 3, 2012·American Journal of Respiratory and Critical Care Medicine·Yuichi TamuraToru Satoh
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G MakiGary K Schwartz
Oct 16, 2009·Cases Journal·Christos KosmasAthanasios Karabelis
Mar 26, 2014·Expert Review of Anticancer Therapy·Emanuela PalmeriniStefano Ferrari
Nov 20, 2012·Expert Opinion on Investigational Drugs·Bruno VincenziGiuseppe Tonini
Feb 11, 2016·Seminars in Cell & Developmental Biology·Ellie Rad, Andrew R Tee
Mar 5, 2016·Current Treatment Options in Oncology·Tarsheen K Sethi, Vicki L Keedy
May 5, 2009·The Lancet Oncology·Hilde BremsEric Legius
May 8, 2009·International Journal of Cancer. Journal International Du Cancer·Chie NishiokaAkihito Yokoyama
Jun 19, 2009·Medicinal Research Reviews·Yong Li, Paul J Cozzi
Oct 19, 2016·International Journal of Cancer. Journal International Du Cancer·Kunihiro IkutaYoshihiro Nishida
Apr 27, 2010·Advances in Anatomic Pathology·José Luis OrdóñezEnrique de Alava
Aug 16, 2013·Expert Review of Anticancer Therapy·Juan Martin-LiberalCharlotte Benson
Nov 2, 2019·Expert Review of Anticancer Therapy·Christopher P WildingPaul H Huang
Aug 26, 2010·Expert Review of Anticancer Therapy·Joseph ChaoGeorge Somlo
Jul 30, 2018·BMC Research Notes·Susan Fischer-HuchzermeyerAnja Harder
Aug 28, 2020·Molecular Cancer Therapeutics·Daniela PucciarelliJean L Nakamura
Apr 11, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Parag P PatwardhanGary K Schwartz
Apr 27, 2019·Molecular Cancer Research : MCR·Justin Korfhage, David B Lombard
Feb 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinsheng YuArie Perry
Apr 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vivek SubbiahNilofer A Azad
Jun 5, 2020·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Lama Binobaid, Michal M Masternak
Aug 28, 2021·International Journal of Molecular Sciences·Teddy MohamadJean-Philippe Brosseau
Oct 17, 2021·Journal of Cellular and Molecular Medicine·Marta Ortega-MuelasRicardo Sánchez-Prieto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.